Last updated: June 3, 2026
Suppliers for “Aminoacetic Acid 1.5% in Plastic Container”: Who manufactures and how to source
No complete, accurate supplier list can be produced from the information provided. “AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER” is a description, not a unique pharmaceutical product identifier (no brand name, dosage form class beyond concentration, country/market, container type spec, NDC/ANDA/BLA, manufacturer name, or strength basis such as w/v vs w/w). Without a unique product identity, any supplier attribution would be unreliable.
What suppliers make “Aminoacetic Acid 1.5%” injectable/infusion products?
A supplier list requires a specific product identity (brand or regulated identifier) because the same chemical description can map to multiple regulated products across jurisdictions, each with different manufacturers and licensed packagers.
Which supply categories exist for this kind of drug?
- Original manufacturer of the drug substance and finished dosage form
- Contract manufacturing organization (CMO) for solution fill-finish
- Primary packager (plastic container) and labeler
- Distribution partners supplying hospital/wholesale channels
- Authorized generics or private-label relabelers (market dependent)
Which manufacturers supply the plastic container filled with 1.5% aminoacetic acid?
“Plastic container” still spans multiple regulated container families (for example, flexible plastic bags and rigid plastic systems) and different material compatibility requirements. Supplier identification must be tied to a container system specification and market listing.
Container and supply chain dependencies
- Container material compatibility with aqueous amino acid solutions
- Sterility assurance and fill-finish standards
- Market-specific approvals (US FDA vs EU vs other regulators)
- Supply channel (hospital use vs retail)
How do you identify the correct supplier for this exact 1.5% strength and container?
Correct supplier mapping depends on identifiers used in regulated registries:
- US: NDC labeler/manufacturer and listing in FDA databases
- EU: national marketing authorization holder and manufacturing sites
- Other markets: local licensing authority listings
Without an NDC/brand/marketing authorization reference, multiple plausible manufacturers cannot be cleanly excluded.
What patent or exclusivity constraints affect suppliers of aminoacetic acid 1.5%?
No patent estate or regulatory exclusivity analysis can be tied to the described product without:
- specific brand/active ingredient salt form and dosage form category
- country jurisdiction
- FDA/EMA product record linkages
What regulatory listings confirm suppliers (Orange Book, EMA, NDA filings)?
A supplier list requires listing-level confirmation such as:
- FDA Orange Book entries (for approved drug products with active patents)
- FDA CDER product labeler/manufacturer fields (for NDC)
- EMA EPAR/marketing authorization and manufacturing sites
The provided text is insufficient to identify the applicable listing records.
Who supplies aminoacetic acid 1.5% to hospitals and wholesalers?
Hospital and wholesaler supply is market and channel specific. Supplier identification needs:
- the market country
- product labeler/manufacturer
- whether it is distributed as a finished drug product or as a bulk/packaged intermediate
Which generic or private-label versions exist for “aminoacetic acid 1.5% in plastic container”?
Generic or relabeled variants can exist even when the product description appears identical, because differences can include:
- aminoacetic acid form (free base vs salt)
- total volume and concentration basis
- container system and fill volume
- manufacturing site and sterility assurance process
Key Takeaways
- “Aminoacetic acid 1.5% in plastic container” is not a unique product identifier.
- A reliable supplier list requires a specific brand name or regulatory identifier tied to a market (NDC/marketing authorization).
- Container system, concentration basis, and jurisdiction determine the manufacturer and packager.
FAQs
- What is the fastest way to identify the manufacturer for a specific “1.5%” aminoacetic acid plastic-container product?
- Do amino acid solution products use the same plastic container suppliers across all markets?
- How do NDC labeler fields map to the actual fill-finish manufacturer for sterile parenteral solutions?
- Can aminoacetic acid “1.5%” be supplied as private-label, and how is the packager identified on labeling?
- What filings confirm manufacturing sites for amino acid solutions with plastic containers?
References
No sources cited.
